U.S. markets closed
  • S&P 500

    4,166.45
    -55.41 (-1.31%)
     
  • Dow 30

    33,290.08
    -533.37 (-1.58%)
     
  • Nasdaq

    14,030.38
    -130.97 (-0.92%)
     
  • Russell 2000

    2,237.75
    -49.71 (-2.17%)
     
  • Crude Oil

    71.50
    +0.46 (+0.65%)
     
  • Gold

    1,763.90
    -10.90 (-0.61%)
     
  • Silver

    25.84
    -0.01 (-0.04%)
     
  • EUR/USD

    1.1865
    -0.0045 (-0.38%)
     
  • 10-Yr Bond

    1.4500
    -0.0610 (-4.04%)
     
  • GBP/USD

    1.3809
    -0.0115 (-0.83%)
     
  • USD/JPY

    110.1500
    -0.0810 (-0.07%)
     
  • BTC-USD

    35,370.26
    -474.68 (-1.32%)
     
  • CMC Crypto 200

    888.52
    -51.42 (-5.47%)
     
  • FTSE 100

    7,017.47
    -135.96 (-1.90%)
     
  • Nikkei 225

    28,964.08
    -54.25 (-0.19%)
     

ALERT: Halper Sadeh LLP Encourages IPHI, EIGI, ARA, and AKER Shareholders to Contact the Firm

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, Dec. 5, 2020 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following mergers:

(PRNewsfoto/Halper Sadeh LLP)
(PRNewsfoto/Halper Sadeh LLP)

Inphi Corporation (NASDAQ: IPHI) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Marvell Technology Group Ltd. for $66.00 in cash and 2.323 shares of stock of the combined company for each Inphi share. If you are an Inphi shareholder, click here to learn more about your rights and options.

Endurance International Group Holdings, Inc. (NASDAQ: EIGI) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to affiliates of Clearlake Capital Group L.P. for $9.50 per share in cash. If you are an Endurance shareholder, click here to learn more about your rights and options.

American Renal Associates Holdings, Inc. (NYSE: ARA) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Innovative Renal Care, LLC, an affiliate of Nautic Partners, LLC, for $11.50 per share in cash. If you are an American Renal shareholder, click here to learn more about your rights and options.

Akers Biosciences, Inc. (NASDAQ: AKER) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with MyMD Pharmaceuticals, Inc. If you are an Akers shareholder, click here to learn more about your legal rights and options.

Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

Cision
Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/alert-halper-sadeh-llp-encourages-iphi-eigi-ara-and-aker-shareholders-to-contact-the-firm-301186817.html

SOURCE Halper Sadeh LLP